MTNR1B and Stroke: In addition, due to the modifiable effects of MTNR1B rs10830963, melatonin supplementation may serve as a potential strategy to reduce stroke risk, particularly for the MTNR1B rs10830963 CC genotype carriers when night shifts are inevitably involved.